95 related articles for article (PubMed ID: 7007505)
1. Evidence for a multistep mechanism of cytolysis by BCG-activated macrophages: the interrelationship between the capacity for cytolysis, target binding, and secretion of cytolytic factor.
Adams DO; Marino PA
J Immunol; 1981 Mar; 126(3):981-7. PubMed ID: 7007505
[No Abstract] [Full Text] [Related]
2. The binding of BCG-activated macrophages to tumor targets stimulates secretion of cytolytic factor.
Johnson WJ; Whisnant CC; Adams DO
J Immunol; 1981 Nov; 127(5):1787-92. PubMed ID: 6795261
[TBL] [Abstract][Full Text] [Related]
3. Effector mechanisms of cytolytically activated macrophages. I. Secretion of neutral proteases and effect of protease inhibitors.
Adams DO
J Immunol; 1980 Jan; 124(1):286-92. PubMed ID: 6985641
[TBL] [Abstract][Full Text] [Related]
4. Characterization of genetic defects in macrophage tumoricidal capacity: identification of murine strains with abnormalities in secretion of cytolytic factors and ability to bind neoplastic targets.
Adams DO; Marino PA; Meltzer MS
J Immunol; 1981 May; 126(5):1843-7. PubMed ID: 6783698
[TBL] [Abstract][Full Text] [Related]
5. The ADCC capacity of macrophages from C3H/HeJ and A/J mice can be augmented by BCG.
Koren HS; Meltzer MS; Adams DO
J Immunol; 1981 Mar; 126(3):1013-5. PubMed ID: 7007498
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of target recognition and destruction in macrophage-mediated tumor cytotoxicity.
Adams DO; Johnson WJ; Marino PA
Fed Proc; 1982 Apr; 41(6):2212-21. PubMed ID: 6804274
[TBL] [Abstract][Full Text] [Related]
7. Effector mechanisms of cytolytically activated macrophages. II. Secretion of a cytolytic factor by activated macrophages and its relationship to secreted neutral proteases.
Adams DO; Kao KJ; Farb R; Pizzo SV
J Immunol; 1980 Jan; 124(1):293-300. PubMed ID: 6985642
[No Abstract] [Full Text] [Related]
8. Release of tumor cytolytic/cytostatic factor(s) by in vitro cisplatin treated macrophages: enhanced tumoricidal activity by increase in osmotic fragility of target cells.
Singh SM; Sodhi A; Pai K; Geetha B
Arch Immunol Ther Exp (Warsz); 1991; 39(1-2):67-73. PubMed ID: 1804054
[TBL] [Abstract][Full Text] [Related]
9. Natural cytotoxic cells against solid tumors in mice. II. Some characteristics of the effector cells.
Paige CJ; Figarella EF; Cuttito MJ; Cahan A; Stutman O
J Immunol; 1978 Nov; 121(5):1827-35. PubMed ID: 361891
[No Abstract] [Full Text] [Related]
10. The requirement for macrophages in the augmentation of natural killer cell activity by BCG.
Tracey DE
J Immunol; 1979 Aug; 123(2):840-5. PubMed ID: 222845
[No Abstract] [Full Text] [Related]
11. The role of transmethylation reactions in regulating the binding of BCG-activated murine macrophages to neoplastic target cells.
Adams DO; Pike MC; Snyderman R
J Immunol; 1981 Jul; 127(1):225-30. PubMed ID: 7240742
[TBL] [Abstract][Full Text] [Related]
12. Attenuation of MHC class II expression in macrophages infected with Mycobacterium bovis bacillus Calmette-Guérin involves class II transactivator and depends on the Nramp1 gene.
Wojciechowski W; DeSanctis J; Skamene E; Radzioch D
J Immunol; 1999 Sep; 163(5):2688-96. PubMed ID: 10453010
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen peroxide and cytolytic factor can interact synergistically in effecting cytolysis of neoplastic targets.
Adams DO; Johnson WJ; Fiorito E; Nathan CF
J Immunol; 1981 Nov; 127(5):1973-7. PubMed ID: 7299120
[TBL] [Abstract][Full Text] [Related]
14. Macrophage activation for tumor cytotoxicity: analysis of intermediary reactions.
Meltzer MS; Ruco LP; Boraschi D; Nacy CA
J Reticuloendothel Soc; 1979 Oct; 26(4):403-15. PubMed ID: 390144
[No Abstract] [Full Text] [Related]
15. Prostaglandin synthesis inhibitors potentiate the BCG-induced augmentation of natural killer cell activity.
Tracey DE; Adkinson NF
J Immunol; 1980 Jul; 125(1):136-41. PubMed ID: 6991599
[No Abstract] [Full Text] [Related]
16. Cytolysis of adenovirus-infected murine fibroblasts by IFN-gamma-primed macrophages is TNF- and contact-dependent.
Day DB; Zachariades NA; Gooding LR
Cell Immunol; 1994 Aug; 157(1):223-38. PubMed ID: 8039246
[TBL] [Abstract][Full Text] [Related]
17. BCG-activated macrophages: comparison as effectors in direct tumor-cell cytotoxicity and antibody dependent cell-mediated cytotoxicity.
Adams DO; Koren HS
Adv Exp Med Biol; 1979; 121B():195-201. PubMed ID: 397747
[No Abstract] [Full Text] [Related]
18. M. bovis BCG induced expression of COX-2 involves nitric oxide-dependent and -independent signaling pathways.
Bansal K; Narayana Y; Patil SA; Balaji KN
J Leukoc Biol; 2009 May; 85(5):804-16. PubMed ID: 19228814
[TBL] [Abstract][Full Text] [Related]
19. Defective tumoricidal capacity of macrophages from P/J mice: tumoricidal defect involves abnormalities in lymphokine-derived activation stimuli and in mononuclear phagocyte responsiveness.
Boraschi D; Meltzer MS
J Immunol; 1980 Aug; 125(2):777-82. PubMed ID: 6993563
[No Abstract] [Full Text] [Related]
20. Activated macrophages and the antitumor action of BCG.
Alexander P
Natl Cancer Inst Monogr; 1973 Dec; 39():127-33. PubMed ID: 4595313
[No Abstract] [Full Text] [Related]
[Next] [New Search]
